Patents Assigned to VALBIOTIS
  • Extract obtained from several plants for use in the prevention and/or treatment of chronic inflammatory bowel diseases
    Patent number: 11712056
    Abstract: The invention relates to a composition comprising at least one specific mixture of molecules for use as a drug or nutritional product in the prevention and/or treatment of chronic inflammatory bowel diseases in humans or animals.
    Type: Grant
    Filed: January 18, 2019
    Date of Patent: August 1, 2023
    Assignees: VALBIOTIS, UNIVERSITE CLERMONT AUVERGNE
    Inventors: Sébastien Peltier, Pascal Sirvent, Yolanda Otero
  • Pharmaceutical active ingredient and use thereof, in particular for the prevention and treatment of metabolic disorders in humans and animals
    Patent number: 11191744
    Abstract: The invention relates to an active pharmaceutical ingredient consisting exclusively of the combination of (1S,3R,4R,5R)-3-{[(2E)-3-(3,4-)dihydroxyphenyl)-2-propenoyl]oxy}-1,4,5-trihydroxycyclohexanecarboxylic acid and of methyl (2S,3E,4S)-4-{2-[2-(3,4-dihydroxyphenyl)ethoxy]-2-oxoethyl}-3-ethylidene-2-(?-D-glucopyranosyloxy)-3,4-dihydro-2H-pyran-5-carboxylate for use as a drug or veterinary product, particularly in the prevention and/or treatment of pathological disorders of carbohydrate and/or lipid metabolism.
    Type: Grant
    Filed: February 13, 2018
    Date of Patent: December 7, 2021
    Assignees: VALBIOTIS, UNIVERSITE CLERMONT AUVERGNE, UNIVERSITE DE LA ROCHELLE, CNRS
    Inventors: Sebastien Peltier, Vivien Chavanelle, Florian Le Joubioux, Pascal Sirvent, Thierry Maugard
  • Composition comprising a mixture of molecules extracted from , and and use to act on carbohydrate and/or fat metabolism
    Patent number: 10813965
    Abstract: A composition comprising at least a mixture of molecules extracted from Chrysanthellum indicum, Cynara scolymus and Lycium barbarum. This composition is in particular useful as a nutritional product or health product to prevent and/or combat fat and/or carbohydrate metabolism disorders in Humans or animals.
    Type: Grant
    Filed: October 20, 2016
    Date of Patent: October 27, 2020
    Assignees: VALBIOTIS, UNIVERSITE CLERMONT AUVERGNE
    Inventors: Sebastien Peltier, Vivien Chavanelle, Pascal Sirvent
  • Compositions and methods for controlling carbohydrate and fat metabolism
    Patent number: 10736930
    Abstract: A composition comprising at least: a single extract obtained from a mixture of at least two plants selected from Chrysanthellum indicum, Cynara scolymus, Vaccinium myrtillus, Piper and Olea europaea. This composition is particularly useful as a nutritional product or health product for preventing and/or combating carbohydrate and/or fat metabolism disorders in humans and animals.
    Type: Grant
    Filed: October 30, 2018
    Date of Patent: August 11, 2020
    Assignees: VALBIOTIS, UNIVERSITE CLERMONT AUVERGNE, UNIVERSITE DE LA ROCHELLE, CNRS
    Inventors: Sebastien Peltier, Pascal Sirvent, Thierry Maugard
  • Compositions and methods for controlling carbohydrate and fat metabolism
    Patent number: 10232005
    Abstract: A composition comprising at least a mixture of molecules obtained at least from: Chrysanthellum indicum, Cynara scolymus, and Vaccinium myrtillus and wherein the mixture of molecules also comprises piperine. The composition is particularly useful as a nutritional product or health product for preventing and/or combating carbohydrate and/or fat metabolism disorders in humans and animals.
    Type: Grant
    Filed: October 18, 2016
    Date of Patent: March 19, 2019
    Assignees: Universite Clermont Auvergne, Valbiotis, Universite De La Rochelle, CNRS
    Inventors: Sebastien Peltier, Pascal Sirvent, Thierry Maugard
  • Compositions and methods for treating diabetes, fatty liver, cardiopathies, insulin resistance, carbohydrate and fat metabolism
    Patent number: 9962420
    Abstract: This disclosure provides compositions formulated in the form of tablets, wafer capsules, gel capsules, sticks, sachets, vials, droppers or in injectable form. The compositions comprise a mixture of: an extract of Chrysanthellum indicum, an extract of Cynara scolymus, an extract of Vaccinium myrtillus, an extract of Olea europaea, and pipeline. This disclosure also provides methods of treating pathological disorders of carbohydrate and/or fat metabolism in a patient by administering to the patient the compositions.
    Type: Grant
    Filed: October 20, 2015
    Date of Patent: May 8, 2018
    Assignees: VALBIOTIS, UNIVERSITE CLERMONT AUVERGNE, UNIVERSITE DE LA ROCHELLE, CNRS
    Inventors: Sebastien Peltier, Pascal Sirvent, Thierry Maugard